William F. Doyle, Executive Chairman at NovoCure Ltd (NVCR), sold 143,774 shares at $12.79 ($1.9M) on 2026-03-03, disclosed to the SEC on 2026-03-05.
Open-market sale of $1.9M NVCR by Executive Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.79 | 50,557 | $646K | 34.6% |
| 2 | $12.79 | 50,557 | $647K | 34.7% |
| 3 | $13.43 | 21,330 | $286K | 15.4% |
| 4 | $13.43 | 21,330 | $286K | 15.4% |
| Total | $12.98 avg | 143,774 | $1.9M | 100% |
| Filing → |
| NVCR | SELL | 2022-08-03 | $117K | — | Filing → |
| NVCR | SELL | 2022-03-09 | $334K | — | Filing → |
| NVCR | SELL | 2021-08-04 | $297K | — | Filing → |